Bavarian Receives $25 Million Milestone Payment from U.S.

Bavarian Nordic A/S said it has received a performance-based milestone payment of $25 million under the contract with the U.S. government to deliver 20 million doses of its smallpox vaccine, IMVAMUNE.

To contact the editor responsible for this story: Christian Wienberg at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.